EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $0 | -100.0% | 348 | -98.8% | 0.00% | – |
| Q1 2023 | $26 | -23.5% | 29,066 | 0.0% | 0.00% | – |
| Q4 2022 | $34 | -100.0% | 29,066 | -0.1% | 0.00% | – |
| Q3 2022 | $219,000 | +130.5% | 29,081 | +91.9% | 0.00% | – |
| Q2 2022 | $95,000 | -24.6% | 15,152 | -0.3% | 0.00% | – |
| Q1 2022 | $126,000 | +59.5% | 15,203 | +0.2% | 0.00% | – |
| Q4 2021 | $79,000 | -22.5% | 15,168 | -0.7% | 0.00% | – |
| Q3 2021 | $102,000 | -55.5% | 15,268 | -43.2% | 0.00% | – |
| Q2 2021 | $229,000 | -3.0% | 26,862 | +0.9% | 0.00% | – |
| Q1 2021 | $236,000 | -11.6% | 26,618 | +22.7% | 0.00% | – |
| Q4 2020 | $267,000 | +107.0% | 21,700 | +36.5% | 0.00% | – |
| Q3 2020 | $129,000 | -15.7% | 15,900 | 0.0% | 0.00% | – |
| Q2 2020 | $153,000 | +41.7% | 15,900 | 0.0% | 0.00% | – |
| Q1 2020 | $108,000 | -69.8% | 15,900 | -33.8% | 0.00% | – |
| Q4 2019 | $358,000 | +45.5% | 24,000 | 0.0% | 0.00% | – |
| Q3 2019 | $246,000 | -3.1% | 24,000 | 0.0% | 0.00% | – |
| Q2 2019 | $254,000 | +309.7% | 24,000 | +344.4% | 0.00% | – |
| Q1 2017 | $62,000 | -1.6% | 5,401 | +0.0% | 0.00% | – |
| Q4 2016 | $63,000 | -12.5% | 5,400 | 0.0% | 0.00% | – |
| Q3 2016 | $72,000 | -32.7% | 5,400 | 0.0% | 0.00% | – |
| Q2 2016 | $107,000 | – | 5,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
| Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
| Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
| ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
| VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
| INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
| 683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
| Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
| Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
| CAXTON CORP | 116,884 | $970,000 | 1.21% |